187 related articles for article (PubMed ID: 29987907)
1. Design, Synthesis and Antibacterial Evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione Hybrids.
Gao Y; Na LX; Xu Z; Zhang S; Wang AP; Lü K; Guo HY; Liu ML
Chem Biodivers; 2018 Oct; 15(10):e1800261. PubMed ID: 29987907
[TBL] [Abstract][Full Text] [Related]
2. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids.
Zhang YZ; Liu HL; He QS; Xu Z
Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237
[TBL] [Abstract][Full Text] [Related]
3. Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids.
Plech T; Kaproń B; Paneth A; Kosikowska U; Malm A; Strzelczyk A; Stączek P; Świątek Ł; Rajtar B; Polz-Dacewicz M
Eur J Med Chem; 2015 Jun; 97():94-103. PubMed ID: 25951434
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids.
Wang R; Yin X; Zhang Y; Yan W
Eur J Med Chem; 2018 Aug; 156():580-586. PubMed ID: 30025351
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents.
Kant R; Singh V; Nath G; Awasthi SK; Agarwal A
Eur J Med Chem; 2016 Nov; 124():218-228. PubMed ID: 27592391
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
Plech T; Wujec M; Kosikowska U; Malm A; Rajtar B; Polz-Dacewicz M
Eur J Med Chem; 2013 Feb; 60():128-34. PubMed ID: 23287058
[TBL] [Abstract][Full Text] [Related]
7. Determination of the primary molecular target of 1,2,4-triazole-ciprofloxacin hybrids.
Plech T; Kaproń B; Paneth A; Kosikowska U; Malm A; Strzelczyk A; Stączek P; Świątek Ł; Rajtar B; Polz-Dacewicz M
Molecules; 2015 Apr; 20(4):6254-72. PubMed ID: 25859782
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and In Vitro Antimycobacterial and Antibacterial Activity of 8-OMe Ciprofloxacin-Hydrozone/Azole Hybrids.
Xu Z; Zhang S; Feng LS; Li XN; Huang GC; Chai Y; Lv ZS; Guo HY; Liu ML
Molecules; 2017 Jul; 22(7):. PubMed ID: 28703766
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity.
Mohammed HHH; Abdelhafez EMN; Abbas SH; Moustafa GAI; Hauk G; Berger JM; Mitarai S; Arai M; Abd El-Baky RM; Abuo-Rahma GEA
Bioorg Chem; 2019 Jul; 88():102952. PubMed ID: 31039471
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antibacterial activity evaluation of moxifloxacin-amide-1,2,3-triazole-isatin hybrids.
Gao F; Ye L; Kong F; Huang G; Xiao J
Bioorg Chem; 2019 Oct; 91():103162. PubMed ID: 31382058
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.
Pokrovskaya V; Belakhov V; Hainrichson M; Yaron S; Baasov T
J Med Chem; 2009 Apr; 52(8):2243-54. PubMed ID: 19301822
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents.
Wang Y; Damu GL; Lv JS; Geng RX; Yang DC; Zhou CH
Bioorg Med Chem Lett; 2012 Sep; 22(17):5363-6. PubMed ID: 22884108
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates.
Faidallah HM; Girgis AS; Tiwari AD; Honkanadavar HH; Thomas SJ; Samir A; Kalmouch A; Alamry KA; Khan KA; Ibrahim TS; Al-Mahmoudy AMM; Asiri AM; Panda SS
Eur J Med Chem; 2018 Jan; 143():1524-1534. PubMed ID: 29126731
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Zhang B
Eur J Med Chem; 2019 Apr; 168():357-372. PubMed ID: 30826511
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety.
Wang S; Jia XD; Liu ML; Lu Y; Guo HY
Bioorg Med Chem Lett; 2012 Sep; 22(18):5971-5. PubMed ID: 22884110
[TBL] [Abstract][Full Text] [Related]
16. Efficient synthesis and antimicrobial activity of some novel S-β-d-glucosides of 5-aryl-1,2,4-triazole-3-thiones derivatives.
Ji D; Lu J; Lu B; Xin C; Mu J; Li J; Peng C; Bao X
Bioorg Med Chem Lett; 2013 Apr; 23(7):1997-2000. PubMed ID: 23466234
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure elucidation of some 4-substituted benzylidene amino-5-[3(5)-methyl-5(3)-phenyl-1H-1-pyrazolyl]-2,4-dihydro-3H-1,2,4- triazole-3-thione derivatives with their antimicrobial activities.
Doğan HN; Büyüktimkin S; Rollas S; Yemni E; Cevikbaş A
Farmaco; 1997; 52(8-9):565-8. PubMed ID: 9507666
[TBL] [Abstract][Full Text] [Related]
18. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
19. 1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents.
Zhang J; Wang S; Ba Y; Xu Z
Eur J Med Chem; 2019 Jul; 174():1-8. PubMed ID: 31015103
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
Sonawane AD; Rode ND; Nawale L; Joshi RR; Joshi RA; Likhite AP; Sarkar D
Chem Biol Drug Des; 2017 Aug; 90(2):200-209. PubMed ID: 28083914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
